- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
Millennium Pharmaceuticals, Inc.가 후원하는 임상 시험
총 4987 건
-
University of Modena and Reggio EmiliaMillennium Pharmaceuticals, Inc.알려지지 않은
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.완전한
-
Northwestern UniversityEli Lilly and Company; Millennium Pharmaceuticals, Inc.종료됨
-
Masonic Cancer Center, University of MinnesotaMillennium Pharmaceuticals, Inc.종료됨
-
University of Michigan Rogel Cancer CenterMillennium Pharmaceuticals, Inc.완전한
-
Northwestern UniversityNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.모집하지 않고 적극적으로미만성 거대 B세포 림프종 | 형질모세포성 림프종 | B세포 림프종 | 성인 버킷 림프종 | MYC 유전자 돌연변이미국
-
Milton S. Hershey Medical CenterTakeda; Millennium Pharmaceuticals, Inc.종료됨
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.완전한
-
Ohio State University Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.종료됨점막 관련 림프조직의 결절외 변연부 B세포 림프종 | 결절 변연부 B세포 림프종 | 재발성 성인 버킷 림프종 | 재발성 성인 미만성 대세포 림프종 | 재발성 등급 1 여포성 림프종 | 재발성 등급 2 여포성 림프종 | 재발성 등급 3 여포성 림프종 | 재발성 맨틀 세포 림프종 | 재발성 변연부 림프종 | 비장 변연부 림프종 | 발덴스트룀 마크로글로불린혈증미국
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.완전한신경내분비성 전립선암 | 소세포 전립선암 | Prostate Adenocarcinoma Plus > 신경내분비 표지자에 대한 50% 면역조직화학적 염색미국
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.완전한
-
Emmanuel Antonarakis, MDMillennium Pharmaceuticals, Inc.빼는
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Karyopharm Therapeutics Inc완전한다발성 골수종 | 재발성 및/또는 불응성 다발성 골수종미국
-
Weill Medical College of Cornell UniversityPfizer; Millennium Pharmaceuticals, Inc.종료됨
-
Louisiana State University Health Sciences Center...Millennium Pharmaceuticals, Inc.빼는
-
Women and Infants Hospital of Rhode IslandMillennium Pharmaceuticals, Inc.종료됨
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Hartford Hospital완전한
-
Icahn School of Medicine at Mount SinaiMillennium Pharmaceuticals, Inc.완전한
-
Kathy MillerMillennium Pharmaceuticals, Inc.; Big Ten Cancer Research Consortium종료됨
-
Mehrdad Abedi, MDMillennium Pharmaceuticals, Inc.완전한
-
Weill Medical College of Cornell UniversityGlaxoSmithKline; Millennium Pharmaceuticals, Inc.완전한
-
University of CincinnatiGenzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.완전한
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.종료됨
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Biologics, Inc.모집하지 않고 적극적으로
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.종료됨
-
Eric Bernicker, MDMillennium Pharmaceuticals, Inc.; The Methodist Hospital Research Institute빼는CD30 양성 림프종 | CD30 양성 고형 종양미국
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.완전한
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.모집하지 않고 적극적으로
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.완전한
-
University of Wisconsin, MadisonMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.완전한암종, 비소세포폐
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.완전한
-
University of California, DavisNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.완전한상세불명의 성인 고형 종양, 프로토콜 특정 | 직장의 점액성 선암종 | 직장의 인장 고리 선암종 | 결장의 점액 선암종 | 결장의 인장 고리 선암종 | IIIA기 결장암 | 재발성 결장암 | 재발성 직장암미국
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.종료됨
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.모집하지 않고 적극적으로
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.완전한
-
University of Southern CaliforniaNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.종료됨
-
Ohio State University Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.; Celgene Corporation완전한
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.완전한
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Pfizer; Millennium Pharmaceuticals, Inc.완전한
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.완전한
-
Trillennium Medical Imaging, Inc.알려지지 않은
-
Fondazione MichelangeloFondazione IRCCS Istituto Nazionale dei Tumori, Milano; Millennium Pharmaceuticals, Inc.완전한
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Millennium Pharmaceuticals, Inc.완전한
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKline; Millennium Pharmaceuticals, Inc.종료됨재발성 성인 미만성 대세포 림프종 | 재발성 등급 1 여포성 림프종 | 재발성 등급 2 여포성 림프종 | 재발성 등급 3 여포성 림프종 | 재발성 맨틀 세포 림프종미국
-
Enanta Pharmaceuticals, IncPharmaceutical Research Associates완전한
-
Enanta Pharmaceuticals, IncPharmaceutical Research Associates완전한
-
Enanta Pharmaceuticals, IncPharmaceutical Research Associates완전한
-
Enanta Pharmaceuticals, IncPharmaceutical Research Associates완전한
-
Enanta Pharmaceuticals, IncPharmaceutical Research Associates완전한